Cargando…
Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy
Glucocorticoid excess suppresses osteocyte remodeling of surrounding bone minerals, causes apoptosis of osteoblasts and osteocytes, and disrupts bone remodeling, eventually, leading to glucocorticoid-induced osteoporosis and bone fragility. Preventing apoptosis and preserving osteocyte morphology co...
Autores principales: | Mazur, Courtney M., Castro Andrade, Christian D., Tokavanich, Nicha, Sato, Tadatoshi, Bruce, Michael, Brooks, Daniel J., Bouxsein, Mary L., Wang, Jialiang S., Wein, Marc N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464962/ https://www.ncbi.nlm.nih.gov/pubmed/36105586 http://dx.doi.org/10.1016/j.isci.2022.105019 |
Ejemplares similares
-
Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin
por: Wang, Jialiang S., et al.
Publicado: (2021) -
A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
por: Sato, Tadatoshi, et al.
Publicado: (2020) -
Pathways Controlling Formation and Maintenance of the Osteocyte Dendrite Network
por: Wang, Jialiang S., et al.
Publicado: (2022) -
The natriuretic peptide receptor agonist osteocrin disperses Pseudomonas aeruginosa biofilm
por: Louis, Melissande, et al.
Publicado: (2023) -
Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling
por: Alemi, A. Sean, et al.
Publicado: (2018)